AstraZeneca Looks to Expand Seroquel's Uses

Wants FDA to approve Seroquel to treat bipolar depression

(January 2, 2006) -- AstraZeneca said it is seeking a new indication for Seroquel, a drug currently approved to treat the manic phase associated with bipolar disorder.

The Anglo-Swedish drug maker is seeking approval from the U.S. Food and Drug Administration to market the drug to treat the depressive episodes associated with bipolar disorder. The drug is also approved to treat schizophrenia, another neurological disorder.

If approved, Seroquel would be the only drug cleared to treat both the depressive and manic episodes associated with bipolar disorder, which affects more than seven million American adults and consists of recurring episodes of mania and depression.

advertisement

Most patients with bipolar disorder are symptomatic almost half of their lives. Almost 50% of patients with bipolar depression attempt suicide, and approximately 10% to 15% commit suicide, the company said.

Seroquel has been on the market since 1997 and reached sales of $2 billion in 2004.

Sources: FDA Website, AstraZeneca Press Release

Last updated: 1/06

Related Information:

• Psychiatric Drugs Linked with Metabolic Problems
• Seroquel May Improve Life for Bipolar Patients
• Seroquel Treats Bipolar Disorder Mania and Depression
• SEROQUEL Examined as Treatment for Depressive Episodes Associated with Bipolar Disorder
• Seroquel With Lithium or Divalproex For Bipolar Mania
• Double Boost for Seroquel
• Seroquel Approved for Treatment of Acute Mania Associated With Bipolar Disorder
• How To Survive Bipolar Disorder
• Family-Focused Therapy Helps Bipolar Patients Cope
• Seroquel Approved for Treatment of Acute Mania Associated With Bipolar Disorder

back to top ~ bipolar news index ~ send page to a friend